New Molecular Dx Player Helixis Raises $10M in Series A Funding | GenomeWeb
Helixis, a newly formed molecular diagnostics firm based in Carlsbad, Calif., announced this week that it has raised $10 million in a Series A round of funding.
 
The firm was co-founded by Alex Dickinson, a former CEO of Luxtera who serves as Helixis’ CEO; David Baltimore, president emeritus and Robert Andrews Millikan professor of biology at the California Institute of Technology; and Axel Scherer, professor of electrical engineering, applied physics and physics at Caltech.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.